Taunk Neil K, Moraes Fabio Y, Escorcia Freddy E, Mendez Lucas Castro, Beal Kathryn, Marta Gustavo N
a Department of Radiation Oncology , Memorial Sloan Kettering Cancer Center , New York , New York , USA.
b Department of Radiation Oncology , Hospital Sírio-Libanês , São Paulo , Brazil.
Expert Rev Anticancer Ther. 2016;16(3):347-58. doi: 10.1586/14737140.2016.1143364. Epub 2016 Feb 9.
Glioblastoma is a common aggressive primary malignant brain tumor, and is nearly universal in progression and mortality after initial treatment. Re-irradiation presents a promising treatment option for progressive disease, both palliating symptoms and potentially extending survival. Highly conformal radiation techniques such as stereotactic radiosurgery and hypofractionated radiosurgery are effective short courses of treatment that allow delivery of high doses of therapeutic radiation with steep dose gradients to protect normal tissue. Patients with higher performance status, younger age, and longer interval between primary treatment and progression represent the best candidates for re-irradiation. Multiple studies are also underway involving combinations of radiation and systemic therapy to bend the survival curve and improve the therapeutic index. In the multimodal treatment of recurrent high-grade glioma, the use of surgery, radiation, and systemic therapy should be highly individualized. Here we comprehensively review radiation therapy and techniques, along with discussion of combination treatment and novel strategies.
胶质母细胞瘤是一种常见的侵袭性原发性恶性脑肿瘤,初次治疗后几乎都会进展并导致死亡。再程放疗是治疗进展性疾病的一种有前景的选择,既能缓解症状,又有可能延长生存期。立体定向放射外科和低分割放射外科等高适形放疗技术是有效的短疗程治疗方法,可实现高剂量治疗性辐射的递送,并具有陡峭的剂量梯度以保护正常组织。身体状况较好、年龄较轻以及初次治疗与病情进展之间间隔较长的患者是再程放疗的最佳候选者。多项研究也在进行中,涉及放疗与全身治疗的联合应用,以改变生存曲线并提高治疗指数。在复发性高级别胶质瘤的多模式治疗中,手术、放疗和全身治疗的使用应高度个体化。在此,我们全面综述放疗及技术,并讨论联合治疗和新策略。